Literature DB >> 22976916

Morphological changes of the thoracic duct and accessory lymphatic channels in patients with chylothorax: detection with unenhanced magnetic resonance imaging.

De-Xin Yu1, Xiang-Xing Ma, Qing Wang, Yang Zhang, Chuan-Fu Li.   

Abstract

OBJECTIVES: To characterise the imaging findings of patients with chylothorax and to identify the leak site using unenhanced MRI.
METHODS: Seven patients with chylothorax and 30 healthy individuals (as the control group) underwent three-dimensional heavily and routine T2-weighted MRI. Morphological changes and diameters of the thoracic duct, chyloma display, and some dilated accessory lymph channels were evaluated and measured. The differences between patients and the control group were compared. The leak sites of the thoracic duct and parietal pleura were also identified.
RESULTS: The patients had a higher display rate of the entire thoracic duct and some accessory lymphatic channels, enlarged diameters and tortuous configuration of the thoracic duct, and existence of chylomas compared with the control group (P < 0.05). Seven leaks of the thoracic duct in five patients and five leaks of the parietal pleura in four patients were identified. Close relationships between the leak of thoracic duct and the chylomas or the meshworks of tiny lymphatics were found (P < 0.05).
CONCLUSION: Unenhanced MRI appears reliable in the detection of morphological changes of thoracic lymphatics and in the identification of chyloma and leak sites in patients with chylothorax, which helps appropriate treatment planning and follow-up.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22976916     DOI: 10.1007/s00330-012-2642-8

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  25 in total

1.  Normal CT appearance of the distal thoracic duct.

Authors:  Ming-Eng Liu; Barton F Branstetter; Joseph Whetstone; Edward J Escott
Journal:  AJR Am J Roentgenol       Date:  2006-12       Impact factor: 3.959

2.  Abdominal confluence of lymph trunks: detectability and morphology on heavily T2-weighted images.

Authors:  Ayse Erden; Suat Fitoz; Banu Yagmurlu; Ilhan Erden
Journal:  AJR Am J Roentgenol       Date:  2005-01       Impact factor: 3.959

3.  Magnetic resonance imaging findings in diffuse lymphangiomatosis: neuroradiological manifestations.

Authors:  A Ozturk; D M Yousem
Journal:  Acta Radiol       Date:  2007-06       Impact factor: 1.990

Review 4.  The diaphragmatic crura and retrocrural space: normal imaging appearance, variants, and pathologic conditions.

Authors:  Carlos S Restrepo; Andres Eraso; Daniel Ocazionez; Julio Lemos; Santiago Martinez; Diego F Lemos
Journal:  Radiographics       Date:  2008 Sep-Oct       Impact factor: 5.333

Review 5.  Chyle leaks: consensus on management?

Authors:  Addy Smoke; Mark H Delegge
Journal:  Nutr Clin Pract       Date:  2008 Oct-Nov       Impact factor: 3.080

6.  Thoracic duct visualization: combined use of multidetector-row computed tomography and magnetic resonance imaging.

Authors:  Takumi Kato; Kei Takase; Hirofumi Ichikawa; Susumu Satomi; Shoki Takahashi
Journal:  J Comput Assist Tomogr       Date:  2011 Mar-Apr       Impact factor: 1.826

7.  Chylothorax.

Authors:  C H Doerr; D L Miller; J H Ryu
Journal:  Semin Respir Crit Care Med       Date:  2001-12       Impact factor: 3.119

8.  Etiology of chylothorax in 203 patients.

Authors:  Clinton H Doerr; Mark S Allen; Francis C Nichols; Jay H Ryu
Journal:  Mayo Clin Proc       Date:  2005-07       Impact factor: 7.616

9.  Quantification of pleural effusions: sonography versus radiography.

Authors:  K L Eibenberger; W I Dock; M E Ammann; R Dorffner; M F Hörmann; F Grabenwöger
Journal:  Radiology       Date:  1994-06       Impact factor: 11.105

10.  Dilated cisternae chyli: a sign of uncompensated cirrhosis at MR imaging.

Authors:  Sachit K Verma; Donald G Mitchell; Diane Bergin; Yulia Lakhman; Amy Austin; Manisha Verma; David Assis; Stevene K Herrine; Laurence Parker
Journal:  Abdom Imaging       Date:  2009 Mar-Apr
View more
  7 in total

Review 1.  Treatment options in patients with chylothorax.

Authors:  Hans H Schild; Christian P Strassburg; Armin Welz; Jörg Kalff
Journal:  Dtsch Arztebl Int       Date:  2013-11-29       Impact factor: 5.594

2.  Localization of thoracic duct using heavily T2W MRI for intractable post-esophagectomy chylothorax-a case report.

Authors:  Yi-Chien Chang; Yi-Ting Yen; Ming-Chung Chang; Yau-Lin Tseng
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

3.  Clinical Significance of New Magnetic Resonance Thoracic Ductography Before Thoracoscopic Esophagectomy for Esophageal Cancer.

Authors:  Junya Oguma; Soji Ozawa; Akihito Kazuno; Miho Nitta; Yamato Ninomiya; Kentaro Yatabe; Tetsu Niwa; Takakiyo Nomura
Journal:  World J Surg       Date:  2018-06       Impact factor: 3.352

4.  Magnetic resonance thoracic ductography assessment of serial changes in the thoracic duct after the intake of a fatty meal.

Authors:  Takakiyo Nomura; Tetsu Niwa; Jun Koizumi; Shuhei Shibukawa; Shun Ono; Yutaka Imai
Journal:  J Anat       Date:  2017-12-11       Impact factor: 2.610

5.  A modified pleurodesis in treating postoperative chylothorax.

Authors:  Yutian Lai; Xi Zheng; Yong Yuan; Tian-Peng Xie; Yong-Fan Zhao; Zi-Jiang Zhu; Yang Hu
Journal:  Ann Transl Med       Date:  2019-10

6.  Anatomic and Functional Evaluation of Central Lymphatics With Noninvasive Magnetic Resonance Lymphangiography.

Authors:  Eun Young Kim; Hye Sun Hwang; Ho Yun Lee; Jong Ho Cho; Hong Kwan Kim; Kyung Soo Lee; Young Mog Shim; Jaeil Zo
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

7.  Lymphatic pathway evaluation in congenital heart disease using 3D whole-heart balanced steady state free precession and T2-weighted cardiovascular magnetic resonance.

Authors:  Vasu D Gooty; Surendranath R Veeram Reddy; Joshua S Greer; Zachary Blair; Riad Abou Zahr; Yousef Arar; Daniel A Castellanos; Sheena Pimplawar; Gerald F Greil; Jeanne Dillenbeck; Tarique Hussain
Journal:  J Cardiovasc Magn Reson       Date:  2021-03-01       Impact factor: 5.364

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.